Cell Cycle

Top Research Topics at Cell Cycle?

The concepts of Cell biology, Cancer research, Cell cycle, Genetics and Molecular biology are tackled in Cell Cycle. The journal explores issues in Cell biology which can be linked to other research areas like Apoptosis, DNA damage and Cell growth. Apoptosis works presented in the journal have a specific focus on Programmed cell death.

Topics in DNA damage explored in Cell Cycle were investigated in conjunction with research in G2-M DNA damage checkpoint and DNA repair. The study of Immunology and how it intertwines with concepts under Stem cell were explored in the presented Cancer research research. The Cell cycle study featured in Cell Cycle draws parallels with the field of Kinase.

Gene, DNA replication and Chromatin are among the areas of Genetics tackled. It focuses on Chromatin research which is adjacent to topics in Histone. Many of the studies tackled connect Mitosis with a similar field of study like Spindle apparatus.

• Cell biology (49.97%)
• Cancer research (26.26%)
• Cell cycle (17.33%)

What are the most cited papers published in the journal?

• The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma (848 citations)
• Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest (791 citations)
• Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression (736 citations)

Research areas of the most cited articles at Cell Cycle:

The published papers are organized to reinforce research efforts on Cell biology, Cancer research, Cell cycle, Genetics and Molecular biology. Cell biology research in the most cited papers involves the investigation of DNA damage studies, all of which are linked to disciplines such as DNA repair. The Cancer research research discussed in the most cited publications can contribute to the expansion of the discourse in closely related subjects like

• Cancer cell which is related to area like Stromal cell,
• Immunology which intersects with area such as Stem cell..

What topics the last edition of the journal is best known for?

• Gene
• Cancer
• Internal medicine

The previous edition focused in particular on these issues:

The journal primarily focuses on research topics in Cancer research, Cell biology, Cell growth, Apoptosis and microRNA. While work presented in Cell Cycle provided substantial information on Cancer research, it also covered topics in Carcinogenesis, Cancer, Gene knockdown, Downregulation and upregulation and Gene silencing. Cell Cycle addresses concerns in the field of Cell biology by exploring it in line with topics in Cell which intersect with Western blot subjects.

The research on Cell growth tackled can also make contributions to studies in the areas of PI3K/AKT/mTOR pathway, Cell cycle, Cell culture and Metastasis. Issues in Apoptosis were discussed, taking into consideration concepts from other disciplines like Retinoblastoma, In vitro and Flow cytometry. The journal facilitates discussions on microRNA that incorporate concepts from other fields like Transfection and Pharmacology.

The most cited articles from the last journal are:

• Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis. (6 citations)
• Splicing regulation in brain and testis: common themes for highly specialized organs. (5 citations)
• Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer's disease. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Cell Cycle (based on the number of publications) are:

• Michael P. Lisanti (106 papers) absent at the last edition,
• Federica Sotgia (68 papers) absent at the last edition,
• Guido Kroemer (65 papers) absent at the last edition,
• Richard G. Pestell (53 papers) absent at the last edition,
• Robert M. Hoffman (52 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Cell Cycle (based on the number of publications) are:

• National Institutes of Health (223 papers) published 1 paper at the last edition, 4 less than at the previous edition,
• Harvard University (191 papers) published 1 paper at the last edition, 4 less than at the previous edition,
• Thomas Jefferson University (135 papers) absent at the last edition,
• University of Texas MD Anderson Cancer Center (124 papers) absent at the last edition,
• French Institute of Health and Medical Research (106 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.35% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.80% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.05% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 7.32% of all publications and 76.83% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.